Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss

Sanofi (NASDAQ:SNY) is one of the 11 Best Annual Dividend Stocks to Buy According to Hedge Funds.

The company expands its product pipeline with major acquisitions despite missing Q2 earnings sales expectations.

The French multinational pharmaceutical and healthcare company, Sanofi (NASDAQ:SNY) focuses on discovering, developing, manufacturing, and marketing a variety of pharmaceutical products, vaccines, and consumer healthcare products. Headquartered in Paris, the company leverages its advanced technologies like AI and mRNA platforms to discover and develop innovative therapies and vaccines.

In a series of recent moves, the company completed the acquisitions of Vigil Neuroscience, a US-based biotechnology company, for approximately $470 million in cash, on August 6, 2025, and Blueprint Medicines on July 18, 2025, for $9.1 billion. It also announced an agreement to acquire British biotech firm Vicebio on July 22, 2025, for $1.15 billion. With these acquisitions, Sanofi (NASDAQ:SNY) aims to expand its product pipeline in critical high-growth areas, including respiratory vaccines, oncology, and immunology.

On the other hand, the company’s second-quarter earnings fell short of sales expectations, with sales of $11.33 billion narrowly missing the consensus forecast. However, it also reported positive regulatory news, with its rilzabrutinib earning orphan designation in the EU and its SAR446523 monoclonal antibody receiving a similar designation in the U.S. on July 24, 2025.

Sanofi (NASDAQ:SNY) offers an annual dividend of $2.20, with 24 hedge funds representing a modest institutional confidence in the stock.

While we acknowledge the potential of SNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Dividend Stocks with a Consistent 3-Year Payout History and 11 Best Energy Dividend Stocks to Invest in

Disclosure: None. This article is originally published at Insider Monkey.